fpl 55712 has been researched along with Chronic Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kay, AB; Lee, TH; Turner-Warwick, M; Walport, MJ; Wilkinson, AH | 1 |
| Young, RN | 1 |
1 review(s) available for fpl 55712 and Chronic Disease
| Article | Year |
|---|---|
Discovery of montelukast: a once-a-day oral antagonist of leukotriene D4 for the treatment of chronic asthma.
Topics: Acetates; Administration, Oral; Animals; Asthma; Chromones; Chronic Disease; Cyclopropanes; Humans; Leukotriene Antagonists; Leukotriene D4; Lung; Quinolines; Sulfides | 2001 |
1 other study(ies) available for fpl 55712 and Chronic Disease
| Article | Year |
|---|---|
Slow-reacting substance of anaphylaxis antagonist FPL 55712 in chronic asthma.
Topics: Adult; Asthma; Chromones; Chronic Disease; Ethers; Female; Humans; Male; Middle Aged; Respiratory Therapy; SRS-A | 1981 |